/Teleflex%20Incorporated%20sign%20at%20office-by%20Tada%20Images%20via%20Shutterstock.jpg)
Teleflex Incorporated (TFX), headquartered in Wayne, Pennsylvania, designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. Valued at $10.36 billion by market cap, the company provides medical technologies designed to improve the health and quality of people’s lives. The global medical technologies provider is expected to announce its fiscal second-quarter earnings for 2024 on Thursday, Aug. 1.
Ahead of the event, analysts expect TFX to report a profit of $3.33 per share on a diluted basis, down 2.4% from $3.41 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.